Literature DB >> 27041562

KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8.

W Zhang1, S Hong1, K P Maniar2, S Cheng1, C Jie3, A W Rademaker4, A M Krensky1,5, C Clayberger1.   

Abstract

High-risk strains of human papillomavirus (HPV) are the causative agents of cervical and anogenital cancers and are associated with 5% of all human cancers. Although prophylactic vaccines targeting a subset of HPV types are available, they are ineffective in HPV-infected individuals. Elucidation of the mechanisms controlling HPV replication may allow development of novel anti-HPV therapeutics. Infectious HPV virions are produced during terminal differentiation of host cells. The process of viral maturation requires synergistic interactions between viral and cellular proteins that leads to amplification of the viral genome and expression of late viral genes. Here we show that the transcription factor Kruppel-like factor 13 (KLF13) has a critical role in the HPV life cycle. KLF13 is overexpressed in HPV-positive keratinocytes and cervical cancer cell lines. Expression of KLF13 in normal cervical epithelium is low but increases significantly in cervical intraepithelial neoplasia and invasive squamous cervical cancer. After HPV infection, the E7 protein suppresses ubiquitin ligase FBW7 expression leading to an increase in KLF13 expression. Reduction of KLF13 with short hairpin RNA in differentiating HPV-positive cells resulted in diminished levels of viral gene expression and genome amplification. Knockdown of KLF13 also reduced the level of the transcription factor signal transducer and activator of transcription 5, which led to the downregulation of the ataxia-telangiectasia mutated DNA damage pathway and the chemokine interleukin-8 (IL-8). In addition, neutralization of IL-8 diminished viral genome amplification in differentiating HPV-positive cells. Thus, KLF13 is critical for the activation of the HPV productive life cycle and is likely involved in initiation and progression of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27041562     DOI: 10.1038/onc.2016.97

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

1.  Overexpression of KLF13 and FGFR3 in oral cancer cells.

Authors:  B J Henson; S M Gollin
Journal:  Cytogenet Genome Res       Date:  2010-06-02       Impact factor: 1.636

2.  Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers.

Authors:  J Fujimoto; H Sakaguchi; I Aoki; T Tamaya
Journal:  Cancer Res       Date:  2000-05-15       Impact factor: 12.701

Review 3.  Human papillomavirus oncoproteins: pathways to transformation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  Nat Rev Cancer       Date:  2010-07-01       Impact factor: 60.716

4.  The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients.

Authors:  D Masuya; C Huang; D Liu; K Kameyama; E Hayashi; A Yamauchi; S Kobayashi; R Haba; H Yokomise
Journal:  Cancer       Date:  2001-11-15       Impact factor: 6.860

5.  JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer.

Authors:  Adrian Britschgi; Rita Andraos; Heike Brinkhaus; Ina Klebba; Vincent Romanet; Urs Müller; Masato Murakami; Thomas Radimerski; Mohamed Bentires-Alj
Journal:  Cancer Cell       Date:  2012-12-11       Impact factor: 31.743

6.  Landscape of genomic alterations in cervical carcinomas.

Authors:  Akinyemi I Ojesina; Lee Lichtenstein; Samuel S Freeman; Chandra Sekhar Pedamallu; Ivan Imaz-Rosshandler; Trevor J Pugh; Andrew D Cherniack; Lauren Ambrogio; Kristian Cibulskis; Bjørn Bertelsen; Sandra Romero-Cordoba; Victor Treviño; Karla Vazquez-Santillan; Alberto Salido Guadarrama; Alexi A Wright; Mara W Rosenberg; Fujiko Duke; Bethany Kaplan; Rui Wang; Elizabeth Nickerson; Heather M Walline; Michael S Lawrence; Chip Stewart; Scott L Carter; Aaron McKenna; Iram P Rodriguez-Sanchez; Magali Espinosa-Castilla; Kathrine Woie; Line Bjorge; Elisabeth Wik; Mari K Halle; Erling A Hoivik; Camilla Krakstad; Nayeli Belem Gabiño; Gabriela Sofia Gómez-Macías; Lezmes D Valdez-Chapa; María Lourdes Garza-Rodríguez; German Maytorena; Jorge Vazquez; Carlos Rodea; Adrian Cravioto; Maria L Cortes; Heidi Greulich; Christopher P Crum; Donna S Neuberg; Alfredo Hidalgo-Miranda; Claudia Rangel Escareno; Lars A Akslen; Thomas E Carey; Olav K Vintermyr; Stacey B Gabriel; Hugo A Barrera-Saldaña; Jorge Melendez-Zajgla; Gad Getz; Helga B Salvesen; Matthew Meyerson
Journal:  Nature       Date:  2013-12-25       Impact factor: 49.962

Review 7.  Interleukin-8 and human cancer biology.

Authors:  K Xie
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

Review 8.  Control of papillomavirus DNA replication and transcription.

Authors:  C Desaintes; C Demeret
Journal:  Semin Cancer Biol       Date:  1996-12       Impact factor: 15.707

Review 9.  Keratinocytes and cytokines.

Authors:  A Gröne
Journal:  Vet Immunol Immunopathol       Date:  2002-09-06       Impact factor: 2.046

10.  Papillomaviruses use recombination-dependent replication to vegetatively amplify their genomes in differentiated cells.

Authors:  Nozomi Sakakibara; Dan Chen; Alison A McBride
Journal:  PLoS Pathog       Date:  2013-07-04       Impact factor: 6.823

View more
  12 in total

Review 1.  DNA damage response is hijacked by human papillomaviruses to complete their life cycle.

Authors:  Shi-Yuan Hong
Journal:  J Zhejiang Univ Sci B       Date:  2017 Mar.       Impact factor: 3.066

2.  Development of human ectocervical tissue models with physiologic endocrine and paracrine signaling†.

Authors:  Kelly E McKinnon; Rhitwika Sensharma; Chloe Williams; Jovanka Ravix; Spiro Getsios; Teresa K Woodruff
Journal:  Biol Reprod       Date:  2020-08-21       Impact factor: 4.285

3.  Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway.

Authors:  Wei Zhang; Ankur S Bhagwath; Zeeshan Ramzan; Taylor A Williams; Indhumathy Subramaniyan; Vindhya Edpuganti; Raja Reddy Kallem; Kerry B Dunbar; Peiguo Ding; Ke Gong; Samuel A Geurkink; Muhammad S Beg; James Kim; Qiuyang Zhang; Amyn A Habib; Sung-Hee Choi; Ritu Lapsiwala; Gayathri Bhagwath; Jonathan E Dowell; Shelby D Melton; Chunfa Jie; William C Putnam; Thai H Pham; David H Wang
Journal:  Mol Cancer Ther       Date:  2021-08-10       Impact factor: 6.261

4.  Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells.

Authors:  Qiang Wang; Ruixian Peng; Boshi Wang; Jifeng Wang; Wandong Yu; Yongzhong Liu; Guowei Shi
Journal:  Cancer Biomark       Date:  2018       Impact factor: 4.388

5.  Topoisomerase IIβ-binding protein 1 activates expression of E2F1 and p73 in HPV-positive cells for genome amplification upon epithelial differentiation.

Authors:  Shiyuan Hong; Junfen Xu; Yan Li; Jorge Andrade; Paul Hoover; Paul J Kaminski; Laimonis A Laimins
Journal:  Oncogene       Date:  2019-01-10       Impact factor: 9.867

6.  Downregulation of KLF13 through DNMT1-mediated hypermethylation promotes glioma cell proliferation and invasion.

Authors:  Rile Wu; Qiang Yun; Jianping Zhang; Jingang Bao
Journal:  Onco Targets Ther       Date:  2019-02-22       Impact factor: 4.147

7.  KLF13 suppresses the proliferation and growth of colorectal cancer cells through transcriptionally inhibiting HMGCS1-mediated cholesterol biosynthesis.

Authors:  Weilong Yao; Yue Jiao; Yanhua Zhou; Xiaoya Luo
Journal:  Cell Biosci       Date:  2020-06-08       Impact factor: 7.133

8.  JAK2 Inhibition Impairs Proliferation and Sensitises Cervical Cancer Cells to Cisplatin-Induced Cell Death.

Authors:  Ethan L Morgan; Andrew Macdonald
Journal:  Cancers (Basel)       Date:  2019-12-04       Impact factor: 6.639

9.  High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.

Authors:  Weijing Zhang; Weiling He; Yongjie Shi; Haifeng Gu; Min Li; Zhimin Liu; Yanling Feng; Nianzhen Zheng; Chuanmiao Xie; Yanna Zhang
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

Review 10.  CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy.

Authors:  Shuliang Chen; Xiao Yu; Deyin Guo
Journal:  Viruses       Date:  2018-01-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.